Search results
Oct 4, 2005 · Michael Shepard is a provider established in Orange, California and his medical specialization is Orthopaedic Surgery with a focus in sports medicine with more than 33 years of experience. He graduated from University Of California, Geffen School Of Medicine in 1992.
Oct 8, 2019 · As an adolescent, H. Michael Shepard was enamored with biology. The interest didn’t feel like a choice; it felt like a compulsion. In September, Shepard and his colleagues received the 2019 Lasker-DeBakey Clinical Medical Research Award for the groundbreaking foundational research that led to the creation of Herceptin.
Michael Sheppard. See Photos. View the profiles of people named Michael Shepard. Join Facebook to connect with Michael Shepard and others you may know. Facebook gives people the power...
Sep 10, 2019 · H. Michael Shepard joined Genentech after completing graduate training with George Malacinski and postdoctoral training with Barry Polisky at Indiana University at Bloomington. Polisky was a recent recruit to Indiana from UCSF, and under his tutelage, Shepard worked out mechanisms by which plasmid copy number is regulated by E .
Dr. Shepard is a highly-experienced and respected leader with many successful ventures in this field—working at Genentech (sold to Roche - $46.8 B USD), Canji, Inc. (bought by Scheirng-Plough) and Halozyme (now valued at $2.6B USD). Widely acknowledged biomarker pioneer and recognized worldwide, Dr. Shepard has received the 2019 Albert Lasker ...
“Michael Shepard demonstrated day in and day out how to lead by an exemplary positive attitude. Mike bent over backwards for his some 300 plus team of Associates during our time together.
- Amazon
H Michael Shepard. NB1011, a phosphoramidate derivative of (E)-5- (2-bromovinyl)-2'-deoxyuridine, is a novel small molecule anticancer agent. NB1011 is selectively active against tumor cells ...
